Bellevue Group »

Abivax SA F shares owned by Bellevue Group

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $117k 1.0k 111.35

More positions owned by Bellevue Group

Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Regeneron Pharmaceuticals (REGN)
Scholar Rock Hldg Corp (SRRK)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Ionis Pharmaceuticals (IONS)
Intuitive Surgical Com New (ISRG)
Miragen Therapeutics (VRDN)
Krystal Biotech (KRYS)
Crinetics Pharmaceuticals In (CRNX)
Abbott Laboratories (ABT)
Nuvalent Inc-a (NUVL)
Amgen (AMGN)
Boston Scientific Corporation (BSX)

View all positions for Bellevue Group

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Morgan Stanley
Vestal Point Capital
Caligan Partners
ADAR1 Capital Management
Citadel Advisors
Westfield Capital Management Company
FMR
Susquehanna International
Helikon Investments
Eversept Partners
Henderson Group
Baker Bros. Advisors

View all funds holding Abivax SA F